TFA
BDTX icon

Toth Financial Advisory’s Black Diamond Therapeutics BDTX Stock Holding History

Toth Financial Advisory’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-35
Closed – – 698
2022
Q1 		$0 Hold
35
– – ﹤0.01% 719
2021
Q4 		$0 Hold
35
– – ﹤0.01% 756
2021
Q3 		$0 Hold
35
– – ﹤0.01% 750
2021
Q2 		$0 Sell
35
-35
-50% -$692 ﹤0.01% 695
2021
Q1 		$2K Hold
70
– – ﹤0.01% 575
2020
Q4 		$2K Hold
70
– – ﹤0.01% 519
2020
Q3 		$2K Buy
+70
New +$2.13K ﹤0.01% 466

Other funds holding BDTX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

Toth Financial Advisory's BDTX Position: Q2 2022 in Review

Toth Financial Advisory sold out of Black Diamond Therapeutics (BDTX) in Q2 2022, closing a stake of 35 shares.

Toth Financial Advisory first reported a position in BDTX in Q3 2020 and held it in 7 quarters. The position peaked at $2K in Q1 2021. 74 funds tracked by Wall St. Rank hold BDTX as of Q2 2022.

  • Toth Financial Advisory reported no remaining Black Diamond Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Toth Financial Advisory sold 35 Black Diamond Therapeutics shares in Q2 2022.
  • Toth Financial Advisory first reported a position in Black Diamond Therapeutics in Q3 2020 and held it in 7 quarters.
  • Toth Financial Advisory's Black Diamond Therapeutics position peaked at $2K in Q1 2021.
  • 74 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2022.

Based on Toth Financial Advisory's 13F filing for Q2 2022, filed 25 Jul 2022.